
Eternal Peptides
Tirzepatide
Finnrick tested 2 samples of Tirzepatide (GLP-1 and GIP antagonist) from Eternal Peptides on 7 May 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Eternal Peptides
Tirzepatide
Tested 2 Samples
Last test 7 May 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Mail in a Sample
We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Eternal Peptides
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
7 May 2025
Quantity | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
7 May 2025 | View | 10mg | 10.300mg | +3.0% | 99.23% | TIRZ042024-02-5 | White Label / Silver Crimp / Green Caps | Lab E | Finnrick | |
7 May 2025 | View | 10mg | 10.500mg | +5.0% | 99.14% | TIRZ042024-02-5 | White Label / Silver Crimp / Green Caps | Lab E | Finnrick |